Brazilian SEC greenlights first Solana ETF; launch hinges on stock exchange approval

The Brazilian Securities and Alternate Fee has accredited the nation’s first Solana exchange-traded fund.
In keeping with Brazilian information outlet Exame, the accredited Solana (SOL) ETF will likely be created by asset managers QR Asset and run by Vortx. Moreover, CF Benchmark’s Solana Greenback Reference Fee Index will function the Solana ETF’s level of reference.
Nonetheless, the report additionally signifies that the launch of the product nonetheless relies on approval by the Brazilian inventory change B3, with the Solana ETF nonetheless at a pre-operational stage.
Whereas the regulator is but to announce when precisely the Solana ETF will develop into obtainable to the Brazilian investing public, QR Asset expressed delight in being a world pioneer for a Solana-based exchange-traded product.
We’re proud to be world pioneers on this section, consolidating Brazil’s place as a number one marketplace for regulated investments in crypto property.
Theodoro Fleury, QR Asset funding director
Brazil has a comparatively lengthy historical past with crypto ETFs, having accredited funding funds in Bitcoin (BTC) and Ethereum (ETH) up to now. QR Asset launched a decentralized finance ETF In February 2022, below the ticker QF111.
The product was benchmarked on the Bloomberg Galaxy DeFi Index, which tracks a few of the largest and most energetic DeFi platforms, together with MakerDAO (MKR), Aave (AAVE), and Uniswap (UNI).
Moreover, Brazil additionally presents BlackRock’s iShares Bitcoin Belief ETF, with the South American model going by the title iShares Bitcoin Belief BDR ETF.
In the US, asset managers reminiscent of VanEck and 21Shares have filed for spot Solana ETFs with the U.S. Securities and Alternate Fee, though the regulator is but to reply.
Surprisingly, BlackRock’s chief funding officer for ETF and index investments, Samara Cohen, not too long ago intimated that the funding big is not going to offer a Solana-based ETF within the close to future.
She cited Solana’s lack of a CME futures and little institutional backing as the explanations for BlackRock’s resolution to forgo the product right now.
